Navigation Links
Technical Briefing: Amgen, PDL BioPharma, Questcor Pharma, and BioCryst Pharma
Date:7/11/2013

LONDON, July 11, 2013 /PRNewswire/ --

On Wednesday, July 10, 2013, shares in biotechnology companies ended mostly higher even as the broader market ended on a mixed note. The major movers in the industry included Amgen Inc. (NASDAQ: AMGN), PDL BioPharma Inc. (NASDAQ: PDLI), Questcor Pharmaceuticals Inc. (NASDAQ: QCOR), and BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX). All these companies are tracked by AAAResearchReports.com. Free technical research reports on AMGN, PDLI, QCOR, and BCRX can be accessed by signing up at:

http://www.aaaresearchreports.com/register/  

Shares in Amgen Inc. rose sharply on Wednesday, extending their gains for the week. The company's shares oscillated between $98.02 and $102.33 before finishing the day 3.79% higher at $102.26. A total of 4.18 million shares were traded which is above the daily average volume of 3.55 million. The company's shares have gained 4.53% so far this week, compared to a gain of 1.27% in the S&P 500. However, in the last three months, the stock has fallen by 5.72%. Download free report on AMGN upon registration at:

http://www.AAAResearchReports.com/AMGN071113.pdf

PDL BioPharma Inc.'s stock edged higher on Wednesday, extending its gains for the week. The company's shares oscillated between $8.06 and $8.15 before closing the session 1.24% higher at $8.15. A total of 1.71 million shares were traded which is below the daily average volume of 1.95 million. PDL BioPharma's shares have gained 3.16% so far this week, and 7.24% in the past three months, thus outperforming the S&P 500. PDLI technical report can be accessed for free by signing up at:

http://www.AAAResearchReports.com/PDLI071113.pdf

Shares in Questcor Pharmaceuticals Inc. edged lower on Wednesday, reversing some of their gains for the week. The company's shares ended the day 1.36% lower at $47.20 after oscillating between $47.04 and $48.57. A total of 1.87 million shares were traded which is below the daily average volume of 2.02 million. Despite Wednesday's pullback, the company's shares have gained 1.20% in the last three days and 63.95% in the last three months. A free report on QCOR can be accessed by registering at:

http://www.AAAResearchReports.com/QCOR071113.pdf

BioCryst Pharmaceuticals Inc.'s stock ended slightly higher on Wednesday, finishing at $1.63, up 0.62% from its previous closing price. The company's shares oscillated between $1.61 and $1.65. A total of 330,626 shares were traded which is less than its daily average volume of 818,150. The company's shares have fallen by 6.32% in the last three months. Register with AAA Research Reports and download research on BCRX for free at:

http://www.AAAResearchReports.com/BCRX071113.pdf

----

EDITOR NOTES:

  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  5. For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.


'/>"/>
SOURCE AAA Research Reports
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Todays Technical View: Elan Corp., Amarin, Seattle Genetics, and Cubist Pharma
2. Invitation to Register: Annual Defense Threat Reduction Agency Basic Research Technical Review
3. BC Technical Acquires MEDX
4. Call for Papers for Pittcon 2014 Technical Program
5. Technical Workshops at OrthoTec 2013 Focus on Risk Management Throughout Medical Device Lifecycle and Robust Material Selection Process Development
6. Formedix to Host Webinar: Discover Define-XML - Practical Uses Today and a Technical Deep Dive on March 14, 2013
7. 20% Off Your Entire Order of Scientific, Technical, Medical (STM) Book Titles Until the End of March at Chemical Publishing Company
8. Technical Analysis on VIVUS and Achillion Pharma: Highlights on These Biotech Companies
9. Technical Analysis on GNC Holdings and Walgreen: Drug Store Stocks Set to Provide Good Returns
10. New England Biolabs New Website Adds Technical Information, Easy Ordering, and Better Search
11. 20% Off Your Entire Order of Scientific, Technical, Medical (STM) Titles Until the End of December at Chemical Publishing Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... BELLINGHAM, Washington, USA (PRWEB) , ... April 27, ... ... society for optics and photonics , joined other scientists, researchers, engineers, and industry ... for measures to strengthen America's ability to compete in the world photonics industry. ...
(Date:4/27/2017)... 27, 2017  Kinexum, a distinguished resource for research, ... the appointment of Thomas C. Seoh as ... M.D., Kinexum founder, who becomes Executive Chairman and will ... clients. Thomas Seoh commented, "I ... mission and lead the firm,s remarkable team of life ...
(Date:4/26/2017)... ... April 26, 2017 , ... Led by ex-FDA official Peggy ... comes to Tampa, San Francisco and Boston in 2017. The 2016 sold-out ... such as Pfizer Inc., Teva Pharmaceuticals, Advaxis, Inc., Ocular Therapeutix Inc., Cell Culture ...
(Date:4/26/2017)... ... 26, 2017 , ... NextSteps 2017, NetDimensions’ annual global user ... this May on the following dates: , ?    London, UK from May 10-11, ?    New ... and Performance Institute will be the opening keynote speaker at the NextSteps ...
Breaking Biology Technology:
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities and ... and behavioral), by technology (fingerprint, AFIS, iris recognition, facial ... and others), by end use industry (government and law ... financial and banking, and others), and by region ( ... , Asia Pacific , and the ...
(Date:3/24/2017)... The Controller General of Immigration from Maldives Mr. Mohamed Anwar ... prestigious international IAIR Award for the most innovative high security ePassport and ... ... Maldives Immigration Controller General, Mr. Mohamed ... the right) have received the IAIR award for the "Most innovative high ...
(Date:3/22/2017)... , March 21, 2017   Neurotechnology ... object recognition technologies, today announced the release of ... (SDK), which provides improved facial recognition using up ... on a single computer. The new version uses ... improve accuracy, and it utilizes a Graphing Processing ...
Breaking Biology News(10 mins):